- Filed
- Dec 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Dec 16, 2024 | 4.27M sh |
| Capex | Q3 2025 · Oct 31, 2024 | $0 |
| Capex | Q3 2025 · Oct 31, 2023 | $47K |
| Operating Cash Flow | Q3 2025 · Oct 31, 2024 | −$2.64M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2023 | −$2.16M |
| Cash And Equivalents | Q3 2025 · Oct 31, 2024 | $754K |
| Cash And Equivalents | Q3 2025 · Jan 31, 2024 | $3.19M |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | $13.91M |
| Stockholders Equity | Q3 2025 · Jul 31, 2024 | $15.9M |
| Stockholders Equity | Q3 2025 · Apr 30, 2024 | $17.3M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $18.81M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $19.75M |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $31.1M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $33.06M |
| Stockholders Equity | Q3 2025 · Jan 31, 2023 | $35.51M |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $11.85M |
| Current Liabilities | Q3 2025 · Jan 31, 2024 | $13.68M |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $22.05M |
| Total Liabilities | Q3 2025 · Jan 31, 2024 | $22.92M |
| Current Assets | Q3 2025 · Oct 31, 2024 | $5.39M |
| Current Assets | Q3 2025 · Jan 31, 2024 | $8.84M |
| Total Assets | Q3 2025 · Oct 31, 2024 | $35.97M |
| Total Assets | Q3 2025 · Jan 31, 2024 | $41.74M |
| Eps Basic | Q3 2025 · Oct 31, 2024 | −$0.61 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | −$2.01 |
| Eps Basic restated | Q3 2025 · Oct 31, 2023 | −$3.15 |
| Eps Basic restated | Q3 2025 · Oct 31, 2023 | −$4.61 |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $2.88M |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $9.06M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $4.12M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $12.08M |
| Rd Expense | Q3 2025 · Oct 31, 2024 | $1.13M |
| Rd Expense | Q3 2025 · Oct 31, 2024 | $3.57M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $1.3M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $4.31M |
| Net Income | Q3 2025 · Oct 31, 2024 | −$2.48M |
| Net Income | Q3 2025 · Oct 31, 2024 | −$8.02M |
| Net Income | Q3 2025 · Jul 31, 2024 | −$2.8M |
| Net Income | Q3 2025 · Apr 30, 2024 | −$2.74M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$11.91M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$17.33M |
| Net Income | Q3 2025 · Jul 31, 2023 | −$2.52M |
| Net Income | Q3 2025 · Apr 30, 2023 | −$2.9M |
| Operating Income | Q3 2025 · Oct 31, 2024 | −$1.98M |
| Operating Income | Q3 2025 · Oct 31, 2024 | −$6.44M |
| Operating Income | Q3 2025 · Oct 31, 2023 | −$12.95M |
| Operating Income | Q3 2025 · Oct 31, 2023 | −$18.54M |
| Revenue | Q3 2025 · Oct 31, 2024 | $4.42M |
| Revenue | Q3 2025 · Oct 31, 2024 | $13.23M |
| Revenue | Q3 2025 · Oct 31, 2023 | $6.13M |
| Revenue | Q3 2025 · Oct 31, 2023 | $17.24M |